These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 12202089)

  • 1. In vivo detection of striatal dopamine release during reward: a PET study with [(11)C]raclopride and a single dynamic scan approach.
    Pappata S; Dehaene S; Poline JB; Gregoire MC; Jobert A; Delforge J; Frouin V; Bottlaender M; Dolle F; Di Giamberardino L; Syrota A
    Neuroimage; 2002 Aug; 16(4):1015-27. PubMed ID: 12202089
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Oxytocin enhances attractiveness of unfamiliar female faces independent of the dopamine reward system.
    Striepens N; Matusch A; Kendrick KM; Mihov Y; Elmenhorst D; Becker B; Lang M; Coenen HH; Maier W; Hurlemann R; Bauer A
    Psychoneuroendocrinology; 2014 Jan; 39():74-87. PubMed ID: 24275006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Evidence for striatal dopamine release during a video game.
    Koepp MJ; Gunn RN; Lawrence AD; Cunningham VJ; Dagher A; Jones T; Brooks DJ; Bench CJ; Grasby PM
    Nature; 1998 May; 393(6682):266-8. PubMed ID: 9607763
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quantitation of carbon-11-labeled raclopride in rat striatum using positron emission tomography.
    Hume SP; Myers R; Bloomfield PM; Opacka-Juffry J; Cremer JE; Ahier RG; Luthra SK; Brooks DJ; Lammertsma AA
    Synapse; 1992 Sep; 12(1):47-54. PubMed ID: 1411963
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dopamine release in nucleus accumbens during rewarded task switching measured by [¹¹C]raclopride.
    Jonasson LS; Axelsson J; Riklund K; Braver TS; Ögren M; Bäckman L; Nyberg L
    Neuroimage; 2014 Oct; 99():357-64. PubMed ID: 24862078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigating expectation and reward in human opioid addiction with [(11) C]raclopride PET.
    Watson BJ; Taylor LG; Reid AG; Wilson SJ; Stokes PR; Brooks DJ; Myers JF; Turkheimer FE; Nutt DJ; Lingford-Hughes AR
    Addict Biol; 2014 Nov; 19(6):1032-40. PubMed ID: 23829344
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mesolimbic dopamine release is linked to symptom severity in pathological gambling.
    Joutsa J; Johansson J; Niemelä S; Ollikainen A; Hirvonen MM; Piepponen P; Arponen E; Alho H; Voon V; Rinne JO; Hietala J; Kaasinen V
    Neuroimage; 2012 May; 60(4):1992-9. PubMed ID: 22348881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Monetary discounting and ventral striatal dopamine receptor availability in nontreatment-seeking alcoholics and social drinkers.
    Oberlin BG; Albrecht DS; Herring CM; Walters JW; Hile KL; Kareken DA; Yoder KK
    Psychopharmacology (Berl); 2015 Jun; 232(12):2207-16. PubMed ID: 25563235
    [TBL] [Abstract][Full Text] [Related]  

  • 9. GBR12909 attenuates amphetamine-induced striatal dopamine release as measured by [(11)C]raclopride continuous infusion PET scans.
    Villemagne VL; Wong DF; Yokoi F; Stephane M; Rice KC; Matecka D; Clough DJ; Dannals RF; Rothman RB
    Synapse; 1999 Sep; 33(4):268-73. PubMed ID: 10421707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of central cholinergic blockade on striatal dopamine release measured with positron emission tomography in normal human subjects.
    Dewey SL; Smith GS; Logan J; Brodie JD; Simkowitz P; MacGregor RR; Fowler JS; Volkow ND; Wolf AP
    Proc Natl Acad Sci U S A; 1993 Dec; 90(24):11816-20. PubMed ID: 8265632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ketamine decreased striatal [(11)C]raclopride binding with no alterations in static dopamine concentrations in the striatal extracellular fluid in the monkey brain: multiparametric PET studies combined with microdialysis analysis.
    Tsukada H; Harada N; Nishiyama S; Ohba H; Sato K; Fukumoto D; Kakiuchi T
    Synapse; 2000 Aug; 37(2):95-103. PubMed ID: 10881030
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine does not decrease striatal dopamine D2 receptor binding in man.
    Aalto S; Hirvonen J; Kajander J; Scheinin H; Någren K; Vilkman H; Gustafsson L; Syvälahti E; Hietala J
    Psychopharmacology (Berl); 2002 Dec; 164(4):401-6. PubMed ID: 12457270
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Imaging human reward processing with positron emission tomography and functional magnetic resonance imaging.
    Urban NB; Slifstein M; Meda S; Xu X; Ayoub R; Medina O; Pearlson GD; Krystal JH; Abi-Dargham A
    Psychopharmacology (Berl); 2012 May; 221(1):67-77. PubMed ID: 22052081
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reward motivation in humans and its relationship to dopamine D
    Caravaggio F; Fervaha G; Browne CJ; Gerretsen P; Remington G; Graff-Guerrero A
    J Psychopharmacol; 2018 Mar; 32(3):357-366. PubMed ID: 29442593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Striatal dopamine release during unrewarded motor task in human volunteers.
    Badgaiyan RD; Fischman AJ; Alpert NM
    Neuroreport; 2003 Aug; 14(11):1421-4. PubMed ID: 12960756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is psychological stress in man associated with increased striatal dopamine levels?: A [11C]raclopride PET study.
    Montgomery AJ; Mehta MA; Grasby PM
    Synapse; 2006 Aug; 60(2):124-31. PubMed ID: 16715491
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ritanserin potentiates the stimulatory effects of raclopride on neuronal activity and dopamine release selectivity in the mesolimbic dopaminergic system.
    Andersson JL; Nomikos GG; Marcus M; Hertel P; Mathé JM; Svensson TH
    Naunyn Schmiedebergs Arch Pharmacol; 1995 Oct; 352(4):374-85. PubMed ID: 8532065
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Striatal dopamine release induced by repetitive transcranial magnetic stimulation of the human motor cortex.
    Strafella AP; Paus T; Fraraccio M; Dagher A
    Brain; 2003 Dec; 126(Pt 12):2609-15. PubMed ID: 12937078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serotonergic modulation of striatal dopamine measured with positron emission tomography (PET) and in vivo microdialysis.
    Dewey SL; Smith GS; Logan J; Alexoff D; Ding YS; King P; Pappas N; Brodie JD; Ashby CR
    J Neurosci; 1995 Jan; 15(1 Pt 2):821-9. PubMed ID: 7823183
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Optimized in vivo detection of dopamine release using 18F-fallypride PET.
    Ceccarini J; Vrieze E; Koole M; Muylle T; Bormans G; Claes S; Van Laere K
    J Nucl Med; 2012 Oct; 53(10):1565-72. PubMed ID: 22933820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.